1. Home
  2. JCE vs QTRX Comparison

JCE vs QTRX Comparison

Compare JCE & QTRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • JCE
  • QTRX
  • Stock Information
  • Founded
  • JCE 2007
  • QTRX 2007
  • Country
  • JCE United States
  • QTRX United States
  • Employees
  • JCE N/A
  • QTRX N/A
  • Industry
  • JCE Trusts Except Educational Religious and Charitable
  • QTRX Biotechnology: Laboratory Analytical Instruments
  • Sector
  • JCE Finance
  • QTRX Industrials
  • Exchange
  • JCE Nasdaq
  • QTRX Nasdaq
  • Market Cap
  • JCE 266.3M
  • QTRX 241.2M
  • IPO Year
  • JCE N/A
  • QTRX 2017
  • Fundamental
  • Price
  • JCE $15.19
  • QTRX $5.72
  • Analyst Decision
  • JCE
  • QTRX Hold
  • Analyst Count
  • JCE 0
  • QTRX 4
  • Target Price
  • JCE N/A
  • QTRX $11.75
  • AVG Volume (30 Days)
  • JCE 49.7K
  • QTRX 463.0K
  • Earning Date
  • JCE 01-01-0001
  • QTRX 11-11-2025
  • Dividend Yield
  • JCE 9.26%
  • QTRX N/A
  • EPS Growth
  • JCE N/A
  • QTRX N/A
  • EPS
  • JCE N/A
  • QTRX N/A
  • Revenue
  • JCE N/A
  • QTRX $125,784,000.00
  • Revenue This Year
  • JCE N/A
  • QTRX N/A
  • Revenue Next Year
  • JCE N/A
  • QTRX $37.89
  • P/E Ratio
  • JCE N/A
  • QTRX N/A
  • Revenue Growth
  • JCE N/A
  • QTRX N/A
  • 52 Week Low
  • JCE $11.64
  • QTRX $4.05
  • 52 Week High
  • JCE $14.28
  • QTRX $15.67
  • Technical
  • Relative Strength Index (RSI)
  • JCE 35.10
  • QTRX 55.15
  • Support Level
  • JCE $15.50
  • QTRX $5.62
  • Resistance Level
  • JCE $15.77
  • QTRX $6.20
  • Average True Range (ATR)
  • JCE 0.26
  • QTRX 0.32
  • MACD
  • JCE -0.04
  • QTRX 0.03
  • Stochastic Oscillator
  • JCE 0.00
  • QTRX 50.00

About JCE Nuveen Core Equity Alpha Fund of Beneficial Interest

Nuveen Core Equity Alpha Fund is a diversified closed-end management investment company. Its investment objective is to provide an attractive level of total return, through long-term capital appreciation and through income and gains. The Fund invests in a portfolio of actively managed large-capitalization U.S. common stocks, using the sub-adviser's proprietary quantitative process designed to provide the potential for long-term outperformance. Additionally, the Fund seeks to reduce the volatility of its returns relative to the returns of the Equity Portfolio over extended periods by writing (selling) index call options and/or call options on custom baskets of securities.

About QTRX Quanterix Corporation

Quanterix Corp is a life sciences company that focuses on developing an ultra-sensitive digital immunoassay platform that advances precision health for life sciences research and diagnostics. The Simoa bead-based and planar array platforms designed by the company enable customers to reliably detect protein biomarkers in low concentrations in blood, serum, and other fluids that are undetectable using conventional, analog immunoassay technologies. Its products include Simoa, Assay Kits, LDTs & Assay Services, Simoa p-Tau 217, Simoa NfL LDT, Simoa p-Tau 181 LDT, Instruments, HD-X Automated Immunoassay Analyzer, SR-X Biomarker Detection System, SP-X Imaging and Analysis System, Simoa Accelerator Laboratory and others. Geographically, It operates in North America, EMEA and Asia Pacific.

Share on Social Networks: